Search Results - "Nosyk, B."

Development and validation of health system performance measures for opioid use disorder in British Columbia, Canada by Nosyk, B., Min, JE, Pearce, LA, Zhou, H., Homayra, F., Wang, L., Piske, M., McCarty, D., Gardner, G., O’Briain, W., Wood, E., Daly, P., Walsh, T., Henry, B.

“…Performance measurement provides an evidence-based means to inform development of interventions to improve the quality of care for people who use opioids. We…”
Get full text

Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia by Homayra, F., Hongdilokkul, N., Piske, M., Pearce, L.A., Zhou, H., Min, J.E., Krebs, E., Nosyk, B.

“…•Individual and provider factors influence buprenorphine/naloxone selection.•Provider-related differences accounted for 48.8 % of selection…”
Get full text

Gender differences in mortality among treated opioid dependent patients by Evans, E, Kelleghan, A, Li, L, Min, J, Huang, D, Urada, D, Hser, Y.I, Nosyk, B

“…Highlights • We assess gender-specific mortality risks suffered by opioid-dependent individuals. • Women have a higher mortality risk compared to the general…”
Get full text

Short term health-related quality of life improvement during opioid agonist treatment by Nosyk, B, Bray, J.W, Wittenberg, E, Aden, B, Eggman, A.A, Weiss, R.D, Potter, J, Ang, A, Hser, Y.-I, Ling, W, Schackman, B.R

“…Highlights • We examine short-term health utility of patients on opioid agonist treatment (OAT). • OAT initially improves health utility across all treatment…”
Get full text

Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities by Panagiotoglou, D., Olding, M., Enns, B., Feaster, D. J., del Rio, C., Metsch, L. R., Granich, R. M., Strathdee, S. A., Marshall, B. D. L., Golden, M. R., Shoptaw, S., Schackman, B. R., Nosyk, B.

“…Since the discovery of the secondary preventive benefits of antiretroviral therapy, national and international governing bodies have called for countries to…”
Get full text

Evidence-based drug policy: It starts with good evidence and ends with policy reform by Nosyk, B, Wood, E

Get full text

Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users by Nosyk, B, Li, L, Evans, E, Huang, D, Min, J, Kerr, T, Brecht, M.L, Hser, Y.I

“…Abstract Aims Characterize longitudinal patterns of drug use careers and identify determinants of drug use frequency across cohorts of primary heroin,…”
Get full text

Cost-effectiveness Analysis Along the Continuum of HIV Care: How Can We Optimize the Effect of HIV Treatment as Prevention Programs? by Nosyk, B., Krebs, E., Eyawo, O., Min, J. E., Barrios, R., Montaner, J. S. G.

“…The cascade of HIV care has been proposed as a useful tool to monitor health system performance across the key stages of HIV care delivery to reduce morbidity,…”
Get full text

Increases in the availability of prescribed opioids in a Canadian setting by Nosyk, B, Marshall, B.D.L, Fischer, B, Montaner, J.S.G, Wood, E, Kerr, T

“…Abstract Background The nonmedical use of prescribed opioids (POs) has increased across North America over the past decade. Our objective was to identify…”
Get full text

Non‐HIV‐related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV‐positive individuals linked to HIV care by Lourenço, L, Nohpal, A, Shopin, D, Colley, G, Nosyk, B, Montaner, JSG, Lima, VD

“…Objectives The aim of the study was to explore non‐HIV‐related health care service (NHRHS) utilization, demographic, clinical and laboratory factors associated…”
Get full text

Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions by Hogg, RS, Nosyk, B, Harrigan, PR, Lima, VD, Chan, K, Heath, K, Wood, E, Kerr, T, Montaner, JSG

Get full text

The ‘Expanded HIV care in opioid substitution treatment’ (EHOST) cluster-randomized, stepped-wedge trial: A study protocol by Nosyk, B, Krebs, E, Min, J.E, Ahamad, K, Buxton, J, Goldsmith, C, Hull, M, Joe, R, Krajden, M, Lima, V.D, Olding, M, Wood, E, Montaner, J.S.G

“…Abstract The public health response to HIV/AIDS has turned its focus onto optimizing health care system delivery to maximize case identification, access and…”
Get full text

Comment on Bershteyn et al: Highlighting the need for investment and innovation in ART retention interventions by Nosyk, B, Humphrey, L

Get full text

Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder by Krebs, E., M.A, Kerr, T., Ph.D, Wood, E., Ph.D., M.D, Nosyk, B., Ph.D

“…Abstract Objectives Health related quality of life (HRQoL) has been increasingly considered an endpoint in evaluations of treatment for substance use…”
Get full text

The effect of homelessness on hospitalisation among patients with HIV/AIDS by Nosyk, B., Li, X., Sun, H., Anis, A. H.

“…The purpose of this study was to determine the effect of homelessness on the costs and patterns of hospitalisation in patients with HIV/AIDS. A retrospective…”
Get full text

Proportional Hazards Frailty Models for Recurrent Methadone Maintenance Treatment by Nosyk, Bohdan, MacNab, Ying C., Sun, Huiying, Fischer, Benedikt, Marsh, David C., Schechter, Martin T., Anis, Aslam H.

“…The authors’ objective in this study was to identify determinants of time to discontinuation of methadone maintenance treatment (MMT) across multiple treatment…”
Get full text

Improving health equity and ending the HIV epidemic in the United States: a distributional cost-effectiveness analysis in six cities by Quan, A.M.L, Mah, C, Krebs, E, Zang, X, Chen, S, Althoff, K, Armstrong, W, Behrends, C.N, Dombrowski, J, Enns, E, Feaster, D.J, Gebo, K, Goedel, W, Golden, M, Marshall, B.D.L, Mehta, S, Pandya, A, Schackman, B.R, Strathdee, S, Sullivan, P, Tookes, H, Nosyk, B

Get full text

HIV-1 Disease Progression During Highly Active Antiretroviral Therapy: An Application Using Population-Level Data in British Columbia: 1996―2011 by NOSYK, Bohdan, JEONG MIN, LIMA, Viviane D, YIP, Benita, HOGG, Robert S, MONTANER, Julio S. G

“…Accurately estimating rates of disease progression is of central importance in developing mathematical models used to project outcomes and guide resource…”
Get full text

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria by NOSYK, Bohdan, AUDOIN, Bertrand, STRATHDEE, Steffanie A, WILLIAMS, Brian, MONTANER, Julio, BEYRER, Chris, CAHN, Pedro, GRANICH, Reuben, HAVLIR, Diane, KATABIRA, Elly, LANGE, Joep, LIMA, Viviane D, PATTERSON, Thomas

“…In recent years, evidence has accumulated regarding the ability of HAART to prevent HIV transmission. Early supportive evidence was derived from observational,…”
Get full text

Costs of Health Resource Utilization Among HIV-Positive Individuals in British Columbia, Canada: Results From a Population-Level Study by Nosyk, Bohdan, Lima, Viviane, Colley, Guillaume, Yip, Benita, Hogg, Robert S., Montaner, Julio S. G.

“…Background Through delayed HIV disease progression, highly active antiretroviral therapy (HAART) may reduce direct medical costs, thus at least partially…”
Get full text